University of Chicago Medicine researchers are focused on understanding and providing accessible treatment for primary progressive aphasia (PPA), a rare form of dementia that impairs language abilities over time. They have found that PPA significantly impacts quality of life and have demonstrated the feasibility of international telemedicine interventions. Their studies have shown that PPA affects individuals at a younger age than other forms of dementia, impacting not only the patients but also their families. By measuring the impact of PPA on quality of life and expanding access to care through telemedicine, researchers aim to provide hope and practical support for those living with this challenging condition.
Source link
Researchers explore the impact of primary progressive aphasia on quality of life
